Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kopnin

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Cell Cycle (Georgetown, Tex.)|January 25, 2017
Myogenic potential of human alveolar mucosa derived cellsVadim L Zorin, Andrey A Pulin, Ilya I Eremin, et al.
International Journal of Molecular Sciences|May 4, 2026
The M1 Paradox: Pro-Tumorigenic Effect of Macrophage Cytotoxicity in Prostate CancerOlga V Kovaleva, Vasiliy V Sinyov, Madina A Rashidova, et al.
Cancers|November 25, 2023
Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary <i>KIT</i> MutationsSergei Boichuk, Pavel Dunaev, Vera Skripova, et al.
International Journal of Molecular Sciences|September 13, 2025
Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-SignalingSergei Boichuk, Firyuza Bikinieva, Pavel Dunaev, et al.
Biochemistry. Biokhimiia|August 31, 2025
STAT3/Snail Signaling and Progression of Hypoxia Tolerance in Breast Cancer CellsOlga E Andreeva, Danila V Sorokin, Alexander M Scherbakov, et al.
Cancers|July 1, 2020
Inhibition of FGF2-Mediated Signaling in GIST-Promising Approach for Overcoming Resistance to ImatinibSergei Boichuk, Aigul Galembikova, Ekaterina Mikheeva, et al.
Cancer Drug Resistance (Alhambra, Calif.)|December 3, 2024
Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axisOlga E Andreeva, Danila V Sorokin, Svetlana V Vinokurova, et al.
Oncotarget|October 4, 2017
γH2AX, 53BP1 and Rad51 protein foci changes in mesenchymal stem cells during prolonged X-ray irradiationAnastasia Tsvetkova, Ivan V Ozerov, Margarita Pustovalova, et al.
Biochemistry. Biokhimiia|January 6, 2009
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cellsL S Agapova, B V Chernyak, L V Domnina, et al.
Cancers|January 10, 2026
Hypoxia-Inducible Factor-1α, a Novel Molecular Target for a 2-Aminopyrrole Derivative: Biological and Molecular Modeling StudySvetlana S Zykova, Tatyana Gessel, Aigul Galembikova, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Cell Cycle (Georgetown, Tex.)|January 25, 2017
Myogenic potential of human alveolar mucosa derived cellsVadim L Zorin, Andrey A Pulin, Ilya I Eremin, et al.
International Journal of Molecular Sciences|May 4, 2026
The M1 Paradox: Pro-Tumorigenic Effect of Macrophage Cytotoxicity in Prostate CancerOlga V Kovaleva, Vasiliy V Sinyov, Madina A Rashidova, et al.
Cancers|November 25, 2023
Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary <i>KIT</i> MutationsSergei Boichuk, Pavel Dunaev, Vera Skripova, et al.
International Journal of Molecular Sciences|September 13, 2025
Claudin-1 Contributes to Gastrointestinal Stromal Tumors (GIST) Resistance to Imatinib Mesylate (IM) via Regulation of FGFR-SignalingSergei Boichuk, Firyuza Bikinieva, Pavel Dunaev, et al.
Biochemistry. Biokhimiia|August 31, 2025
STAT3/Snail Signaling and Progression of Hypoxia Tolerance in Breast Cancer CellsOlga E Andreeva, Danila V Sorokin, Alexander M Scherbakov, et al.
Cancers|July 1, 2020
Inhibition of FGF2-Mediated Signaling in GIST-Promising Approach for Overcoming Resistance to ImatinibSergei Boichuk, Aigul Galembikova, Ekaterina Mikheeva, et al.
Cancer Drug Resistance (Alhambra, Calif.)|December 3, 2024
Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axisOlga E Andreeva, Danila V Sorokin, Svetlana V Vinokurova, et al.
Oncotarget|October 4, 2017
γH2AX, 53BP1 and Rad51 protein foci changes in mesenchymal stem cells during prolonged X-ray irradiationAnastasia Tsvetkova, Ivan V Ozerov, Margarita Pustovalova, et al.
Biochemistry. Biokhimiia|January 6, 2009
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cellsL S Agapova, B V Chernyak, L V Domnina, et al.
Cancers|January 10, 2026
Hypoxia-Inducible Factor-1α, a Novel Molecular Target for a 2-Aminopyrrole Derivative: Biological and Molecular Modeling StudySvetlana S Zykova, Tatyana Gessel, Aigul Galembikova, et al.
Pageof 17